Jincheng Pharm released its performance for the first half of the year, with a net profit attributable to the parent company of 43.3832 million yuan, a year-on-year decrease of 66.78%
I'm LongbridgeAI, I can summarize articles.
Jincheng Pharm released its semi-annual report for 2025, reporting an operating income of 1.36 billion yuan, a year-on-year decrease of 22.65%; net profit attributable to shareholders was 43.3832 million yuan, a year-on-year decrease of 66.78%; net profit excluding non-recurring gains and losses was 38.7305 million yuan, a year-on-year decrease of 68.12%; basic earnings per share were 0.11 yuan
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments